Company Information
 
 
 Stock Code Search Company Search
 
Company ProfileCompany StructureProfit & LossBalance Sheet
杭州德適生物科技股份有限公司 Code:  02526
HANGZHOU DIAGENS BIOTECHNOLOGY CO., LTD. Website: http://www.diagens.com
Income Statement
  2025/12
RMB($)
Change 2024/12
RMB($)
2023/12
RMB($)
Turnover164,424,000133.716%70,352,00052,844,000
Operating Profit / (Loss)(67,161,000)--(43,294,000)(56,182,000)
Exceptional Items--------
Profit / (Loss) of Associated Co. & Jointly Controlled Entity25,000--(95,000)(2,000)
Profit / (Loss) before Taxation(67,136,000)--(43,389,000)(56,184,000)
Taxation(1,000)--14,00068,000
Minority Interests0--00
Profit / (Loss) Attributable to Shareholders(67,137,000)--(43,375,000)(56,116,000)
 
Net Interest Income / (Expense)(57,000)--(20,425,000)(15,819,000)
Depreciation & Amortization11,023,000-19.109%13,627,0007,510,000
Directors Remuneration----1,482,0001,496,000
 
EPS / (LPS) (cts)--------
DPS (cts)--------
 
Dividend Payout Ratio (%)--------
NBV Per Share ($)--------
Financial Ratio
  2025/12
RMB($)
Change 2024/12
RMB($)
2023/12
RMB($)
Operating Margin (%)(40.846)%--(61.539)%(106.317)%
Interest Coverage Ratio (x)--------
ROAA (%)(31.369)%--(20.009)%--
ROAE (%)(39.503)%--(24.902)%--
 
Copyright ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.